ERBB2 and breast carcinoma: NK cells are innate lymphocytes that recognize and kill tumor targets directly or upon CD16 engagement on antibody-bound cells, triggering the release of cytotoxic granules, chemokines, and proinflammatory cytokines.79 The strongest data supporting the role of NK cells in breast cancer are in HER2+ breast cancer.